Lataa...
Pharmacokinetics and haemodynamics of candesartan cilexetil in hypertensive patients on regular haemodialysis
AIMS: The pharmacokinetic profile of candesartan cilexetil might be altered in patients with end-stage renal disease (ESRD). No data are available about the pharmacokinetics and haemodynamics of the angiotensin II receptor antagonist candesartan cilexetil in ESRD patients on regular haemodialysis (H...
Tallennettuna:
| Päätekijät: | , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Blackwell Science Inc
1999
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2014260/ https://ncbi.nlm.nih.gov/pubmed/10383542 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1046/j.1365-2125.1999.00939.x |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|